Musk reveals switching to Lila for weight loss: better efficacy than Novo Nordisk's competing products, with fewer side effects

Musk revealed on social media platform X on Wednesday that he is using Mounjaro from Lilly to lose weight. Musk posted a photo of himself dressed as Santa Claus on X, standing next to a Christmas tree with the caption "Ozempic Santa Claus." He later confirmed in multiple posts that he is indeed using a drug similar to Ozempic to lose weight. He explained, "Strictly speaking, I am using Mounjaro, but that name doesn't sound so interesting." Ozempic is a diabetes drug under Novo Nordisk, and Wegovy is the company's weight loss product, both of which have the same active ingredient, semaglutide. Mounjaro, on the other hand, is a diabetes drug introduced by Lilly, with the same active ingredient as the company's weight loss drug Zepbound, namely tirzepatide. Musk revealed that he initially tried using Ozempic to lose weight, but because high doses of the drug would cause him to "fart and burp like Barney from The Simpsons." "Mounjaro seems to have fewer side effects and better results," he added.